<DOC>
	<DOCNO>NCT02324725</DOCNO>
	<brief_summary>This study evaluate biological marker treatment opioid dependent individual extend release formulation opioid antagonist naltrexone . The biological measure include functional MRI , blood level naltrexone metabolite , urine toxicology behavioral test probe various aspect personality , memory , reward processing attention .</brief_summary>
	<brief_title>Biomarkers Injectable Extended Release Naltrexone Treatment</brief_title>
	<detailed_description>This study use blood oxygenation level dependent ( BOLD ) functional magnetic resonance imaging ( fMRI ) examine brain predictor adherence outcomes opioid antagonist therapy . Opioid-dependent intravenous heroin user offer 3 monthly injection extended-release naltrexone ( XRNTX ) contingent upon successful outpatient non-opioid detoxification , additional 4 week follow . Brain responses heroin-related picture record use fMRI prior 1st XRNTX injection approximately 2 week thereafter 1st XRNTX injection . Primary clinical variable include number injection ( maximum 3 ) accept participant , change self-reported craving opioids exposure drug-related visual cue brain fMRI session , urine level ten commonly abused substance self-report cigarette use .</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . DSMIVTR diagnosis opioid dependence , active opioid use , confirm urine toxicology screen selfreported monthly intravenous heroin use 2 week past 3 month 2. urine toxicology screen negative opioids detoxification 3. good physical health indicate history physical examination , screen blood workup urinalysis . 1. chronic medical illness ; 2. current use medication potentially confound brain activity , antidopaminergic agent , antidepressant betablockers ; 3. current DSMIVTR Axis I psychiatric disorder opioid nicotine dependence ; 4. life time history concurrent IV cocaine heroin ( speedball ) administration ; 5. pregnancy breastfeeding ; 6. history clinically significant head trauma ; 7. contraindication naltrexone treatment include medical condition require opioid analgesic , e.g . chronic pain plan surgery , obesity , elevate liver enzyme ( &gt; 3 time upper limit normal ) , failure complete opioid detoxification 8. contraindication MRI , i.e . indwell magnetically active foreign body phobia enclosed space</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>naltrexone</keyword>
	<keyword>neuroimaging</keyword>
	<keyword>heroin</keyword>
	<keyword>addiction</keyword>
	<keyword>dependence</keyword>
	<keyword>opioid</keyword>
	<keyword>VivitrolÂ®</keyword>
	<keyword>functional magnetic resonance imaging</keyword>
</DOC>